Macrophages are abundant in the tumor microenvironment. They are highly plastic and able to acquire pro-tumoral phenotypes in response to microenvironmental stimuli. When we treated RAW 264.7 macrophages with inhibitors of various oncogenic pathways, we found that the focal adhesion kinase (FAK) inhibitors PF573228 and TAE226 could induce cell multinucleation by suppressing furrowing and cytokinesis. This failure in cytokinesis involves Rac1, whose activity is elevated by FAK inhibitors, and the p21-activated kinases, comprising the downstream effectors of Rac. We also investigated the influence of cell multinucleation on macrophage physiology in RAW 264.7 cells. This is the first study to report that FAK inhibitors suppress furrow ingression and early cytokinesis. Of note, we found that FAK inhibitors caused a dramatic increase in pro-tumoral cytokines in multinuclear cells, suggesting the potential to convert macrophages into pro-tumoral phenotypes.
Macrophages are phagocytic cells derived from bone marrow precursors and are widely distributed in the body. They are highly plastic and can change both their phenotype and function in response to local stimuli [1] . Generally, macrophages exhibit a spectrum of phenotypes, including pro-inflammatory (or classically activated) (M1) macrophages and anti-inflammatory (or alternatively activated) (M2) macrophages [2] . Macrophages are abundant in the tumor microenvironment. Clinical and experimental data are available demonstrating that macrophages provide support to tumor cells at various stages of tumor progression, with different pro-tumoral phenotypes secreting specific pro-tumoral cytokines [3, 4] . Small-molecule kinase inhibitors targeting oncogenic kinases and pathways are promising anticancer therapeutics. Potent kinase inhibitors delivered into the tumor microenvironment may also become a stimulus for regulating macrophage physiology and even influencing their phenotype. Accordingly, it is necessary to investigate how macrophages respond to these anticancer agents in the microenvironment.
Focal adhesion kinase (FAK) is a cytoplasmic nonreceptor protein tyrosine kinase and a scaffold protein localized to focal adhesions. FAK is multifunctional, playing vital roles in the cell adhesion, migration, and regulation of many signaling kinases [5] . FAK is overexpressed and activated in many invasive and metastatic tumors and has been proposed as an anticancer target [6] . Small-molecule FAK inhibitors and dual FAK/Pyk2 inhibitors are emerging chemotherapeutic agents [7] . They prevent tumor growth, metastasis, and angiogenesis in preclinical models and four of them are in clinical trials (phase I and phase II).
Cytokinesis is the final stage of cell division that partitions a single cell into two. Cytokinesis is a wellorchestrated process [8] . It is initiated by assembly of the contractile ring that anchors to the cell membrane. Constriction of the contractile ring drives the formation and ingression of the cleavage furrow, which largely separates the cytoplasm into two daughter cells. Near the end of cytokinesis, the two daughter cells remain connected by a narrow intercellular bridge, termed the midbody. The last step is abscission, completely splitting the daughter cells apart [9] .
Previous studies have reported the influence of FAK inhibitors on cytokinesis. Taneja et al. [10] explored how focal adhesions shape the cleavage furrow and reported that FAK inhibitor PF573228 increased focal adhesions and reduced furrow ingression from the bottom of the cell in HeLa cells and epithelial cells. Kamranvar et al. [11] reported that integrin signaling via FAK-Src was involved in abscission via the proper timing of stepwise recruitment of midbody proteins. Treating mitotic cells with FAK inhibitor PF562271 disturbed the temporal regulation of these proteins and caused abscission failure in human fibroblasts [11] . Considering the multifunctional characteristics of FAK, FAK inhibitors may have multiple effects on cytokinesis.
In this study, we incubated small-molecule kinase inhibitors of various oncogenic pathways with the murine macrophage cell line RAW 264.7 and found that FAK inhibitors PF573228 and TAE226 can induce multinuclear cell formation in a dose-and time-dependent manner, whereas other inhibitors, including inhibitors targeting the AKT, PI 3 K, PKC, p38, ERK, JNK and TGF-b pathway, could not. Furthermore, the ability of inducing multinucleation of FAK inhibitors was not restricted to macrophage cell lines. They were also found to be potent in two cancer cell lines. We found that cell multinucleation was induced by FAK inhibitors via suppression of furrow ingression and cytokinesis. Next, we investigated why FAK inhibitors caused cytokinesis failure. Finally, we further investigated the influence of cell multinucleation on the macrophage physiology in RAW 264.7 cells, aiming to determine how macrophages respond to FAK inhibitor-induced cell multinucleation.
Materials and methods
Cell culture RAW 264.7 cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) and were cultured in high glucose Dulbecco's modified Eagle's medium (Gibco, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (Gibco) in a humidified incubator at 37°C with 5% CO 2 . For multinuclear cell induction, cells were seeded at 1.5 9 10 4 cells per well in 96-well plate, and after 24 h, cells were treated with indicated concentrations of PF573228 or TAE226 to induce cell multinucleation. NCI-H522 and HCT 116 were obtained from ATCC and cultured in accordance with the manufacturer's instructions.
Immunocytochemistry
Cells were seeded on coverslips in 24-well plates and incubated with PF573228 or TAE226 or vehicle for the time periods indicated. Cells were fixed for 10 min with 1% paraformaldehyde in PBS at room temperature and then permeabilized by incubation in 0.1% Triton X-100 in PBS for 10 min. Then cells were stained with Phallodin-fluorescein isothiocyanate (FITC) (KeyGen Biotech, Nanjing, China) for 30 min to label F-actin and then incubated with 4 0 ,6-diamidino-2-phenylindole (DAPI) (GeneCopeia, Rockville, MD, USA) for 15 min to stain nuclei. Fluorescence images were acquired using confocal microscopy (Leica, Wetzlar, Germany) or conventional fluorescence microscopy (Leica).
Multinuclear index and multinuclear cell index
Cells were stained by DAPI and Phallodin-FITC. Nuclei in individual cells were counted under a fluorescence microscope. Cells with three or more nuclei were identified as multinuclear cells. Multinuclear index were determined by calculating the percentage of the number of nuclei in multinuclear cells per total number of nuclei in three independent fields. The multinuclear cell index was determined by calculating the proportion of multinuclear cells in three independent fields. Index values are given as the mean AE SD.
In vitro cytotoxicity assay
In total, 1. 
Live-cell imaging
Live-cell imaging was performed using a Live Cell Workstation AF6000 (Leica). Imaging was performed under cell culture conditions at 37°C with 5% CO 2 . Images of each position were obtained every 10 min with DMI6000B using a 9 40 objective. Images for cells transfected with pcDNA3.1-mH2B-OFP cells were acquired in bright field and the red channel and overlayed. Other images were acquired in bright field. For quantitative analysis of cell behavior and fate, PF573228 or vehicle was added when cells were seeded and cells were followed from 4 to 24 h after they were seeded on the plate (1 9 10 4 cells per well in a 24-well plates).
Rac1 activation assay
Active Rac1 (Rac1-GTP) was precipitated from cell lysates using a Rac1 activation magnetic beads pulldown assay kit (Millipore, Billerica, MA, USA) in accordance with the manufacturer's instructions. Rac1-GTP and total Rac1 were detected by western blotting using the anti-Rac1 antibody supplied with the kit.
Western blot analysis
Cells were lysed in radioimmunoprecipitation assay buffer containing 1% phosphotase inhibitors, phenylmethanesulfonyl fluoride and protease inhibitors (KeyGen Biotech). Cell lysates were subjected to SDS/PAGE and transferred onto polyvinylidene fluoride membranes (Millipore). Protein bands were incubated with anti-b-actin, anti-tumor necrosis factor (TNF)-a (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-p-FAK (Y566/567), anti-FAK and anti-p-P38 antibodies, as well as secondary antibodies conjugated to horseradish peroxidase (Cell Signaling Technology, Beverly, MA, USA), and then detected using a ChemiDoc XRS + system (Bio-Rad, Hercules, CA, USA).
Phagocytosis assay
RAW 264.7 cells were seeded on coverslips in 24-well plates and then induced to form multinuclear cells by PF573228. Pretreated fluoresbrite polychromatic red microspheres (Polysciences, Inc., Warrington, PA, USA) were mixed with cells and incubated for 10 h and then cells were washed three times with PBS to remove free microspheres. Cells on the coverslips were observed by confocal microscopy (Leica) after staining with Phallodin-FITC and DAPI.
Real-time quantitative RT-PCR
Total RNA was extracted using TRIzol reagent (Invitrogen) and cDNAs were generated using M-MLV reverse transcriptase (Promega, Madison, WI, USA). Real-time quantitative RT-PCR was performed in CFX96 (Bio-Rad) using SYBR Select Master Mix (Invitrogen), cDNA templates, and specific primers. b-Actin was the reference gene. Data were analyzed using the 2 ÀMMCt method. Primers were selected from Primer Bank [12] . The sequences of the primers used are available on request. All real-time quantitative RT-PCR experiments were performed in duplicate and were repeated three times.
Statistical analysis
Values were reported as the mean AE SD of three independent experimental replications. An unpaired Student's t-test (two-tailed) was used to make comparisons between mean values.
Results
FAK inhibitors PF573228 and TAE226 can induce multinuclear cell formation in a dose-and timedependent manner RAW 264.7 is a murine monocyte/macrophage-derived cell line and is mononuclear under normal culture conditions. We treated RAW 264.7 cells with inhibitors of various oncogenic pathways, including inhibitors of AKT (MK-2206), PI 3 K (LY294002), FAK (PF573228, TAE226), PKC (Sotrastaurin), p38 (SB202190), ERK (FR 180204), JNK (SP600125), and TGF-b receptor type I/II (LY2109761). We found that FAK inhibitors can induce multinucleation of RAW 264.7 cells, whereas vehicle-treated control cells remained the mononuclear phenotype (Fig. 1A) . None of the other inhibitors tested could induce such a phenomenon.
To quantify cell multinucleation, we determined a 'multinuclear index' by calculating the percentage of the number of nuclei in multinuclear cells per total number of nuclei. Cells with three or more nuclei were identified as multinuclear cells and we also determined a 'multinuclear cell index' by calculating their proportion. Nuclei in individual cells were counted under a microscope after nuclei and actin filaments were visualized by staining with DAPI and Phallodin-FITC.
As shown in Fig. 1 , the ability of PF573228 and TAE226 to induce multinuclear cell formation was dose and time dependent. The dynamics of multinuclear index and multinuclear cell index were similar. The multinuclear index of PF573228 (72 h) at 2.5, 5, and 10 lM was 23.6 AE 6.8%, 87.1 AE 3.3%, and 60.4 AE 12.2%, respectively, whereas the multinuclear cell index was 7.9 AE 1%, 50.8 AE 7.2%, and 38 AE 8.8%, respectively (Fig. 1B) . The multinuclear index of TAE226 (72 h) at 0.5, 1, and 2 lM was 33.3 AE 4.3%, 57.2 AE 9.4%, and 55.5 AE 1.2%, respectively, whereas the multinuclear cell index was 12.9 AE 0.5%, 32.4 AE 3.8%, and 27.2 AE 10.4%, respectively (Fig. 1B) . These two indices became maximum with 5 lM for PF573228 and 1 lM for TAE226 and declined at a higher concentration. This may be a result of their substantial cytotoxicity at a higher concentration (Fig. 1C) . These two indices also increased as the incubation time increased (Fig. 1D) . Multinuclear cells could last for 6 days or longer until nutrients in the medium totally run off if there were no culture medium changes.
Next, we tested nonmacrophage cells lines. NCI-H522 is a human non-small-cell lung cancer cell line and HCT 116 is a human colon cancer cell line. As shown in Fig. 1E , PF573228 was also effective with respect to inducing multinucleation in NCI-H522 and HCT 116. When treated with 5 lM PF573228 for 72 h, the multinuclear index and multinuclear cell index of NCI-H522 were 70.1 AE 12.2% and 53.4 AE 9.9%, respectively, and those of HCT 116 were 82.6 AE 4.2% and 46.6 AE 3.2%, respectively (Fig. 1E) , reflecting that the potency of PF573228 to induce multinucleation in NCI-H522 and HCT 116 cells was similar to that in RAW 264.7 cells. 
Multinuclear cells induced by FAK inhibitors were formed as a result of cytokinesis failure
We first inspected whether FAK inhibitor-induced multinuclear cells were generated by cell fusion because macrophages are one of several cell types in the body that can undergo cell-cell fusion. To test this hypothesis, cells transfected with different fluorescent protein-coding plasmids (EGFP and RFP) were used in a mixed culture experiment. RAW 264.7-EGFP and RAW 264.7-RFP were treated with 5 lM PF573228 and 1 lM TAE226, respectively, in a mixed culture experiment. HCT 116-EGFP and HCT 116-RFP were also used in a mixed culture experiment. However, as shown in Fig. 2A , we could barely detect any doublepositive cells, indicating that cell fusion cannot explain this phenomenon.
To investigate this issue, we performed live-cell imaging and found that cytokinesis failure was responsible. RAW 264.7 cells were followed from 6 to 48 h and from 24 to 66 h after they were incubated with 5 lM PF573228 or vehicle. In the PF573228 treatment group, we found that the majority of cells showed a continuous increase in cell size. Furthermore, in some cases, we also observed furrow regression.
To better track the changes, we then used RAW 264.7 cells transfected with plasmid coding histone H2B tagged with orange fluorescent protein (mH2B-OFP) to perform live-cell imaging. We observed an increase in nuclear number and cell size without cytoplasmic division, as shown in Fig. 2B (see also Movie S1). In some cases, multinuclear cells divided into two daughter cells and daughter cells were also multinuclear cells, as shown in Fig. 2C (see also Movie S2). In some cases, two daughter cells incompletely divided and 're-fused' together. In case shown in Fig. 2D ,E (see also Movie S3), furrow regression occurred twice (first time, Fig. 2D ; second time, Fig. 2E ).
Sustained elevation of Rac1 activity was involved in PF573228-induced cytokinesis failure
Rac1 is a small G-protein that is able to regulate many cellular processes, including the cell cycle, cytoskeletal rearrangement, and cell growth, etc. Research on FAK À/À macrophages found that FAK knockout caused high levels of activated Rac1 [13] . Accordingly, we inspected the effect of PF573228 on FAK and Rac1 activity in RAW 264.7 cells by measuring phospho-FAK and Rac1-GTP. We observed that PF573228 caused blockade of FAK phosphorylation and sustained activation of Rac1 for at least 96 h (Fig. 3A) . Research on Hela cells [14] , Caenorhabditis elegans embryos [15] and Drosophila melanogaster S2 cells [16] demonstrated that the suppression of Rac1 activity by GTPase-activating protein (GAP) in the centralspindlin complex is essential for cytokinesis. Therefore, we proposed that sustained elevation of Rac1 activity by PF573228 may explain the PF573228-induced multinuclear cell formation. p21-activated kinases (PAKs) are downstream effectors of Rac1. To test our hypothesis, we used inhibitors of Rac (EHT1864) and PAKs (IPA-3 for PAK1, FRAX597 for PAK1/PAK2/PAK3). RAW 264.7 cells were pre-incubated with inhibitors for 24 h and then 5 lM PF573228 was added. Some 72 h later, the multinuclear index and multinuclear cell index were calculated. As shown in Fig. 3B , EHT1864 significantly and dose dependently reversed PF573228-induced multinucleation. Pre-incubating with EHT1864 (25 and 50 lM) reduced the multinuclear index of 5 lM PF573228 from 71.5 AE 5.5% to 44.1 AE 3.2% (P < 0.005) and 32.8 AE 5.7% (P < 0.005), respectively, and reduced the multinuclear cell index of PF573228 from 38.8 AE 2.8% to 29.8 AE 7.3% and 15.9 AE 5.5% (P < 0.005), respectively. FRAX597 was more potent: 20 lM FRAX597 pretreatment completely reversed PF573228-induced multinucleation (P < 0.001) and 2.5 lM FRAX597 reduced these two indices of 5 lM PF573228 by almost one-half (P < 0.005). IPA-3 had little effect. Our data indicate that PF573228 caused cell multinucleation by affecting cytokinesis via Rac1 and its downstream effectors PAKs.
Unsuppressed Rac1 activity was reported to disrupt contractile ring constriction during cytokinesis [14, 16] . To check defects in furrow ingression in PF573228-treated RAW 264.7 cells, we used live-cell imaging to monitor cells from 4 to 24 h and analyzed the behavior and fate of the first generation. As shown in Fig. 3C , PF573228 greatly increased the fraction of cells that did not initiate efficient furrowing. In the PF573228 treatment group, 10.6% of cells divided successfully, 62.1% of cells did not initiate furrowing, 10.6% of cells underwent furrow regression and 16.7% of cells underwent cell death (Fig. 3D , see also Movie S4), whereas in the control group, 80.4% of cells divided successfully, 9.8% of cells did not divide and 9.8% of cells underwent cell death (Fig. 3D , see also Movie S5). Furthermore, we analyzed live-cell imaging recordings over a longer time (from 6 to 48 h) and, in some cases, we observed asymmetric furrowing in the PF573228 treatment group (Fig. 3E) , whereas in control cells, furrow ingression took place symmetrically at the cell equator (Fig. 3E) . These data indicate that PF573228 caused defective furrow ingression.
PF573228-induced multinucleation in RAW 264.7 macrophages caused enhanced phagocytosis and dramatic changes in cyto/chemokine production We first investigated whether multinucleation of RAW 264.7 cells affected phagocytosis ability. We performed a phagocytosis assay by observing the internalization of fluorescent beads (6 lm) by confocal microscopy. As shown in Fig. 4A , multinuclear cells resulting from PF573228 treatment for 3 days exhibited enhanced phagocytosis activity compared with control cells. Macrophages are highly plastic to stimuli. Accordingly, we next investigated whether multinucleation of RAW 264.7 cells affected macrophage phenotype by inspecting the gene expression of M1 and M2 markers. We compared M1 and M2 marker expression in multinuclear cells as a result of PF573228 treatment for 48 h with that in vehicle-treated control mononuclear cells by quantitative RT-PCR. Interestingly, all of the tested markers were up-regulated in PF573228-induced multinuclear cells, including interleukin (IL)-1b, IL-1a, IL-6, TNF-a, inducible nitric oxide synthase, Toll-like receptor (TLR)4, and TLR2 as M1 macrophage markers (Fig. 4B) and CD206, Arg-1, IL-10, chemokine (C-C motif) ligand (CCL)17, CCL22, and matrix metallopeptidase (MMP)12 as M2 macrophage markers (Fig. 4C) . Some of them even reached a hundred-fold increase. These data suggest that PF573228-induced multinuclear RAW 264.7 cells were activated to some extent and also that they may exhibit an intermediate phenotype between the M1 and M2 phenotypes. To investigate the dynamics of cytokine expression, we measured the expression of IL-1b, IL-1a, and TNF-a by quantitative RT-PCR at the indicated time points after PF573228 treatment. These genes were upregulated at 48 h; however, none of them were upregulated before 12 h. Moreover, IL-1a and IL-1b were even remarkably down-regulated before 12 h and they were almost 90% off at 12 h (Fig. 4D) . The expression pattern of TNF-a was also confirmed by western blotting (Fig. 4E) . Furthermore, we measured the phospho-p38 level during the process because the p38 pathway has been reported to regulate cytokine production [17] . The activation of p38 was observed at 48-h time point (Fig. 4D ) in a pattern similar to the up-regulation of most of the cytokines tested.
Our data showed that FAK inhibitor-induced cell multinucleation in RAW 264.7 macrophages had a great influence on their physiology, including enhanced phagocytosis activity; an increase for all tested M1 and M2 phenotype markers; a dramatic increase for several pro-tumoral cytokines (10-or even 100-fold); and a significant reversion of the expression pattern of some phenotype markers, from marked down-regulation by incubation with PF573228 within 12 h to marked up-regulation after 48 h.
Discussion
This study reported a novel phenomenon in that FAK inhibitors PF573228 and TAE226 potently induced cell multinucleation in macrophages and other cell lines. Multinuclear cells are usually caused by cell-cell fusion or failed cytokinesis. Data from live-cell imaging and mixed culture experiments (Fig. 2) support the idea that cell multinucleation induced by FAK inhibitors was caused by cytokinesis failure.
Using live-cell imaging, we found that PF573228 greatly increased the fraction of cells not initiating efficient furrowing compared with control cells, and we also observed asymmetric furrowing induced by PF573228, indicating that PF573228 caused defective furrowing. Rac1 is active when binding to GTP and can be suppressed by GAPs. CYK4, a component of the centralspindlin, is a GAP that suppresses Rac1 activity. Bastos et al. [14] reported that the expression of constitutively active Rac1 or depletion of endogenous CYK4 lead to cytokinesis failure in Hela cells and that such defects could be rescued by inhibiting Rac1 or its downstream effectors PAK1 and PAK2. Bastos et al. [14] also found that CYK4 GAP mutant cells failed to suppress Rac1 activity at the furrow region in dividing cells, and these cells were more adherent during cytokinesis compared with wild-type cells. Based on their findings, they proposed a model in which equatorial cell adhesion prevents efficient contractile ring constriction. Suppressing Rac1 by CYK4 in the centralspindlin reduces cell adhesion at the furrow region and thus facilitates contractile ring constriction [14, 18] . This model could be supported by researches in C. elegans embryos [15] and D. melanogaster S2 cells [16] . Our observations are also consistent with this model. In this study, we found that PF573228 sustainedly activated Rac1 in RAW 264.7 cells (Fig. 3A) . Inhibitors of Rac1 (EHT1864) and PAKs (FRAX597) significantly and dose dependently reversed PF573228-induced multinucleation (Fig. 3B) . Especially, 20-lM FRAX597 almost completely inhibited PF573228-induced multinucleation. These data indicate that PF573228-induced cytokinesis failure involved Rac1 and its downstream effectors PAKs.
Previous studies have demonstrated that FAK signaling mediates focal adhesion disassembly and inhibiting FAK stabilizes focal adhesions [19] [20] [21] . Taneja et al. [10] reported that PF573228 treatment for 10 min resulted in increased focal adhesion and decreased furrow ingression from the bottom of the cell. Focal adhesion underneath the cleavage furrow disappeared just before furrow ingression and furrow ingression from the bottom of the cell decreased in cells under higher adhesion conditions [10] . Such data suggest that enhanced adhesion caused by FAK inhibitor would generate resistance to contractile ring constriction. Although it is not clear whether Rac1 plays a role in focal adhesion stabilization caused by FAK inhibitors, this research lends further support to our finding that FAK inhibitors suppressed furrow ingression in the early stage of cytokinesis.
We also observed late-stage cytokinesis failure. A small fraction of cells failed to complete cytokinesis after furrow ingression, resulting in furrow regression. In the study investigating CYK4 GAP mutant Hela cells by Bastos et al. [14] , both early-stage failure (defective furrowing) and late-stage failure (abscission defects) in cytokinesis were observed. However, the ratio of the two was not mentioned. The data obtained suggest that the inhibitory effect of unsuppressed Rac1 activity on furrowing could also result in abscission defects. In addition, Kamranvar et al. [11] reported that, in human fibroblast cells, integrin signaling via FAK-Src participates in the temporal regulation of CEP55 recruitment to the midbody via PLK1, with this being critical for the initiation of abscission process. Inhibiting FAK with FAK inhibitor PF562271 increased the degradation of PLK1 and enhanced the premature recruitment of CEP55, resulting in abscission failure. Incubating cells in suspension with a lack of integrin-FAK signaling had the same effects on abscission as inhibiting FAK using PF562271 [11] . According to these findings, it is likely that the furrow regression observed in this study was a result of the inhibitory effects of FAK inhibitors on the abscission process via multiple pathways, probably including the FAK-Rac1 pathway and the integrin-FAK-PLK1-CEP55 pathway.
We note that Kamranvar et al. [11] did not report furrowing suppression by FAK inhibitor in their study. They used BJ fibroblast cells and, in this study, we used RAW 264.7 macrophages. The difference may be a result of the cell type-specific response to FAK inhibitors or cell type specificity in the regulation of cytokinesis that has been suggested in previous studies [11, 22] . There are two possible reasons for the difference. One is that FAK inhibitor could not elevate Rac1 activity in BJ fibroblasts. The other is BJ fibroblasts are more resistant to the inhibitory effect of Rac1 on contractile ring constriction, so that FAK inhibitor did not show suppression of furrowing ingression in the study by Kamranvar et al. [11] .
This study reports that FAK inhibitors suppress furrow ingression and early cytokinesis and we have also revealed its mechanism. Our findings provide insight into how FAK inhibitors influence cell physiology. Multinucleation resulting from defective cytokinesis may cause chromosomal instability. In cancer cells, this may be one of the mechanisms by which FAK inhibitors cause cancer cell growth arrest. In macrophages, it may cause other problems. Macrophages are abundant in the tumor microenvironment and are very susceptible to environmental stimuli, and so we investigated the effect of multinucleation on macrophage physiology.
Of note, we observed a dramatic increase of cyto/ chemokines in multinuclear RAW 264.7 cells (Fig. 4) : IL-1b (120.5 AE 9.7-fold), IL-1a (54.5 AE 10.1-fold), IL-6 (42.5 AE 3.4-fold), CCL22 (59.2 AE 1.5-fold), CCL17 (130.8 AE 1.5-fold), and MMP12 (503.2 AE 2.5-fold). Among them, CCL22, CCL17, IL-6, and IL-1b are wellknown pro-tumoral cytokines that are able to stimulate tumor cell proliferation and invasion, as well as promote the suppression of antitumor immune responses [23] [24] [25] [26] . This study found that FAK inhibitor-induced cell multinucleation resulted in a dramatic increase in several pro-tumoral cytokines, suggesting the possibility of macrophages becoming pro-tumoral. We have also demonstrated that FAK inhibitor-induced cytokinesis failure and cell multinucleation deserve more detailed investigation, including substantial in vivo studies.
In summary, this study first discovered that cell multinucleation was induced by FAK inhibitors PF573228 and TAE226 in macrophages and some cancer cells lines as a result of the suppression of furrowing and cytokinesis. We revealed that such cytokinesis failure involved the elevation of Rac1 activity caused by FAK inhibitors and PAKs, the downstream effectors of Rac were also involved. Then, we investigated the influence of multinucleation on macrophage physiology in RAW 264.7 macrophages. We found a dramatic increase of pro-tumoral cytokines in multinuclear cells, suggesting the possibility of macrophages becoming pro-tumoral. This study highlights the need to investigate how FAK inhibitors influence cell physiology and also how macrophages respond to antitumor agents.
